批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2001/12/13 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2016/06/09 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/09/26 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/08/21 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/06/04 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/03/28 |
SUPPL-18(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2010/07/20 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2007/09/14 |
SUPPL-13(补充) |
Approval |
Labeling-Package Insert,Labeling-Container/Carton Labels |
N/A
|
|
|
| 2007/08/10 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/01/19 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/11/24 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/10/15 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 2002/11/15 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:PIMECROLIMUS; 剂型/给药途径:CREAM;TOPICAL; 规格:1%; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021302 |
001 |
NDA |
ELIDEL |
PIMECROLIMUS |
CREAM;TOPICAL |
1% |
Prescription |
Yes |
Yes |
AB |
2001/12/13
|
BAUSCH |
| 209345 |
001 |
ANDA |
PIMECROLIMUS |
PIMECROLIMUS |
CREAM;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2018/12/27
|
ACTAVIS LABS UT INC |
| 211769 |
001 |
ANDA |
PIMECROLIMUS |
PIMECROLIMUS |
CREAM;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2019/08/29
|
GLENMARK PHARMS LTD |